www.lifesciencehistory.com
Open in
urlscan Pro
192.169.179.88
Public Scan
Submitted URL: https://nevadalifesciences.com/
Effective URL: https://www.lifesciencehistory.com/
Submission: On August 01 via api from US — Scanned from DE
Effective URL: https://www.lifesciencehistory.com/
Submission: On August 01 via api from US — Scanned from DE
Form analysis
2 forms found in the DOMName: mc-embedded-subscribe-form — POST https://washingtonlifescience.us8.list-manage.com/subscribe/post?u=5404fe71177a7feecfd1149f9&id=9fd4d0c530&f_id=00cb24e3f0
<form action="https://washingtonlifescience.us8.list-manage.com/subscribe/post?u=5404fe71177a7feecfd1149f9&id=9fd4d0c530&f_id=00cb24e3f0" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate"
target="_blank" novalidate="novalidate">
<div id="mc_embed_signup_scroll">
<h2>Subscribe</h2>
<div class="indicates-required"><span class="asterisk">*</span> indicates required</div>
<div class="mc-field-group"><label for="mce-EMAIL">Email Address <span class="asterisk">*</span></label><input type="email" name="EMAIL" class="required email" id="mce-EMAIL" required="" value="" aria-required="true"></div>
<div id="mce-responses" class="clear">
<div class="response" id="mce-error-response" style="display: none;"></div>
<div class="response" id="mce-success-response" style="display: none;"></div>
</div>
<div aria-hidden="true" style="position: absolute; left: -5000px;"><input type="text" name="b_5404fe71177a7feecfd1149f9_9fd4d0c530" tabindex="-1" value=""></div>
<div class="clear"><input type="submit" name="subscribe" id="mc-embedded-subscribe" class="button" value="Subscribe"></div>
</div>
</form>
GET https://www.lifesciencehistory.com/
<form role="search" method="get" class="search-form" action="https://www.lifesciencehistory.com/">
<label>
<span class="screen-reader-text">Search for:</span>
<input type="search" class="search-field" placeholder="Search …" value="" name="s">
</label>
<input type="submit" class="search-submit" value="Search">
<div class="kadence-search-icon-wrap"><span class="kadence-svg-iconset"><svg aria-hidden="true" class="kadence-svg-icon kadence-search-svg" fill="currentColor" version="1.1" xmlns="http://www.w3.org/2000/svg" width="26" height="28"
viewBox="0 0 26 28">
<title>Search</title>
<path
d="M18 13c0-3.859-3.141-7-7-7s-7 3.141-7 7 3.141 7 7 7 7-3.141 7-7zM26 26c0 1.094-0.906 2-2 2-0.531 0-1.047-0.219-1.406-0.594l-5.359-5.344c-1.828 1.266-4.016 1.937-6.234 1.937-6.078 0-11-4.922-11-11s4.922-11 11-11 11 4.922 11 11c0 2.219-0.672 4.406-1.937 6.234l5.359 5.359c0.359 0.359 0.578 0.875 0.578 1.406z">
</path>
</svg></span></div>
</form>
Text Content
Skip to content Facebook Instagram Linkedin LifeScienceHistory.com History made daily * Home * Company Directory * CareersExpand * Find Your Job * Advertise Your Job * News and History * Toons & Teasers * Small World Search LifeScienceHistory.com History made daily Toggle Menu DNA PIONEERS Our Hero DNA recognize Francis Crick, Maurice Wilkins, James Watson and Rosalind Franklin for their determination of the structure of DNA. LIFE SCIENCE NEWS, COMPANIES, JOBS, AND MORE! Since 1997, our focus has been to provide the best resource to information related to the life science industry. LifeScienceHistory.com, our new site, is a resource for history-making life science news, company information, job opportunities, original cartoons and so much more! TODAY IN LIFE SCIENCE * * YELLOW FEVER KILLED MORE THAN 5,000 PEOPLE IN PHILADELPHIA On Aug. 1, 1793, it was reported that a fever, now known as ‘Yellow Fever’ killed more than… Read More COMPANY DIRECTORY See All Companies Access a comprehensive, ‘daily-updated directory’ of life science companies located throughout Canada and the U.S., all password free. If you are a life science company or non-profit research organization that has been omitted from the directory, we apologize. To be included or to submit updates, please email your company or organization information to: info@LifeScienceHistory.com. CAREERS View More Careers Advertise your candidate openings and find your career options at LifeScienceHistory.com! Are you tired of high advertising rates? Are you tired of being overwhelmed with less-than-quality candidates? Advertise your openings with the LifeScienceHistory.com and find your top candidates. Our job posting options allow you to cost effectively expand your recruitment while maximizing your budget to locate the quality employees you need. EXPLORE CAREER OPPORTUNITIES SENIOR SCIENTIST, POTENCY ASSAYS FOR ANTIBODIES Requisition ID: 5273 Location: Bothell, Washington, US Do you want to join a team where the mission is meaningful, the challenges are complex, and you can directly see the results of your hard work? Lundbeck Seattle BioPharmaceuticals (Lu-SBP), located in Bothell,… Read More Senior Scientist, Potency Assays for AntibodiesContinue NEWS & HISTORY Peruse breaking news from today and last week, as well as discoveries, events and news from last year and beyond. Read News And History PAXLOVID LED TO BETTER OUTCOMES IN HOSPITALIZED COVID COHORT THAN VEKLURY OR BOTH DRUGS On Jul. 24, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated with the antiviral drug nirmatrelvir–ritonavir (Paxlovid) are at lower risk for death, intensive care unit (ICU) admission, and need for ventilation than those… SCIENTISTS IDENTIFIED POSSIBLE NEW TRANSMISSION FACTOR IN HOSPITAL-ACQUIRED KLEBSIELLA INFECTIONS On Jul. 22, 2024, scientists at ADA Forsyth Institute (AFI) announced they had identified a critical factor that may contribute to the spread of hospital-acquired infections (HAIs), shedding light on why these infections are so difficult to combat. Their study… STUDY SHOWS TINY ANIMALS STEAL ANTIBIOTIC RECIPES FROM BACTERIA On Jul. 19, 2024, a study led by the University of Oxford reported that a group of small freshwater animals protect themselves from infections using antibiotic recipes stolen from bacteria that could help develop future medicines. The little-known creatures called… SMART PHONE INVENTION REVOLUTIONIZES ABILITY TO DETECT HARMFUL CHEMICALS On Jul. 16, 2024, Texas A&M University scientists announced receipt of a patent for a hand-held cellphone-based Raman spectrometer system that may revolutionize chemical analysis. This new system integrates lenses, a diode laser and a diffraction grating — a small… SUPPLEMENTS SLOW DISEASE PROGRESSION DURING LATE STAGE OF “DRY” AGE-RELATED MACULAR DEGENERATION On Jul. 16, 2024, researchers at the National Institutes of Health (NIH) reported they have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage… FOSSILS OF ANCIENT CHROMOSOMES DISCOVERED On Jul. 11, 2024, a team led by scientists from Baylor College of Medicine, University of Copenhagen, and Centre Nacional d’Anàlisi Genòmica and Centre for Genomic Regulation reported discovering fossils of ancient chromosomes in the remains of a woolly mammoth… CEPI AND WHO URGE BROADER RESEARCH STRATEGY FOR COUNTRIES TO PREPARE FOR THE NEXT PANDEMIC On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called on researchers and governments to strengthen and accelerate global research to prepare for the next pandemic. They emphasized the importance of expanding… NEW INITIATIVE LAUNCHED TO ADVANCE MRNA VACCINE DEVELOPMENT AGAINST HUMAN AVIAN INFLUENZA (H5N1) On Jul. 29, 2024, a new project that aims to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries was launched. The Argentinian manufacturer Sinergium Biotech will… EUROPEAN COMMISSION APPROVES PFIZER’S DURVEQTIX® (FIDANACOGENE ELAPARVOVEC), A ONE-TIME GENE THERAPY FOR ADULTS WITH HEMOPHILIA B On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX® (fidanacogene elaparvovec), a gene therapy for the treatment of severe and moderately severe hemophilia B (congenital factor IX deficiency) in adult patients… CIRM APPROVED $8 MILLION AWARD FOR PLASMA CELL DISORDER THERAPY, $27 MILLION TO BOOST COLLABORATION AMONG CALIFORNIA RESEARCHERS On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded nearly $35 million to fund clinical research to address a rare plasma cell disorder and six new Shared… PAXLOVID LED TO BETTER OUTCOMES IN HOSPITALIZED COVID COHORT THAN VEKLURY OR BOTH DRUGS On Jul. 24, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated with the antiviral drug nirmatrelvir–ritonavir (Paxlovid) are at lower risk for death, intensive care unit (ICU) admission, and need for ventilation than those… SCIENTISTS IDENTIFIED POSSIBLE NEW TRANSMISSION FACTOR IN HOSPITAL-ACQUIRED KLEBSIELLA INFECTIONS On Jul. 22, 2024, scientists at ADA Forsyth Institute (AFI) announced they had identified a critical factor that may contribute to the spread of hospital-acquired infections (HAIs), shedding light on why these infections are so difficult to combat. Their study… STUDY SHOWS TINY ANIMALS STEAL ANTIBIOTIC RECIPES FROM BACTERIA On Jul. 19, 2024, a study led by the University of Oxford reported that a group of small freshwater animals protect themselves from infections using antibiotic recipes stolen from bacteria that could help develop future medicines. The little-known creatures called… SMART PHONE INVENTION REVOLUTIONIZES ABILITY TO DETECT HARMFUL CHEMICALS On Jul. 16, 2024, Texas A&M University scientists announced receipt of a patent for a hand-held cellphone-based Raman spectrometer system that may revolutionize chemical analysis. This new system integrates lenses, a diode laser and a diffraction grating — a small… SUPPLEMENTS SLOW DISEASE PROGRESSION DURING LATE STAGE OF “DRY” AGE-RELATED MACULAR DEGENERATION On Jul. 16, 2024, researchers at the National Institutes of Health (NIH) reported they have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage… FOSSILS OF ANCIENT CHROMOSOMES DISCOVERED On Jul. 11, 2024, a team led by scientists from Baylor College of Medicine, University of Copenhagen, and Centre Nacional d’Anàlisi Genòmica and Centre for Genomic Regulation reported discovering fossils of ancient chromosomes in the remains of a woolly mammoth… CEPI AND WHO URGE BROADER RESEARCH STRATEGY FOR COUNTRIES TO PREPARE FOR THE NEXT PANDEMIC On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called on researchers and governments to strengthen and accelerate global research to prepare for the next pandemic. They emphasized the importance of expanding… NEW INITIATIVE LAUNCHED TO ADVANCE MRNA VACCINE DEVELOPMENT AGAINST HUMAN AVIAN INFLUENZA (H5N1) On Jul. 29, 2024, a new project that aims to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries was launched. The Argentinian manufacturer Sinergium Biotech will… EUROPEAN COMMISSION APPROVES PFIZER’S DURVEQTIX® (FIDANACOGENE ELAPARVOVEC), A ONE-TIME GENE THERAPY FOR ADULTS WITH HEMOPHILIA B On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX® (fidanacogene elaparvovec), a gene therapy for the treatment of severe and moderately severe hemophilia B (congenital factor IX deficiency) in adult patients… CIRM APPROVED $8 MILLION AWARD FOR PLASMA CELL DISORDER THERAPY, $27 MILLION TO BOOST COLLABORATION AMONG CALIFORNIA RESEARCHERS On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded nearly $35 million to fund clinical research to address a rare plasma cell disorder and six new Shared… PAXLOVID LED TO BETTER OUTCOMES IN HOSPITALIZED COVID COHORT THAN VEKLURY OR BOTH DRUGS On Jul. 24, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated with the antiviral drug nirmatrelvir–ritonavir (Paxlovid) are at lower risk for death, intensive care unit (ICU) admission, and need for ventilation than those… SCIENTISTS IDENTIFIED POSSIBLE NEW TRANSMISSION FACTOR IN HOSPITAL-ACQUIRED KLEBSIELLA INFECTIONS On Jul. 22, 2024, scientists at ADA Forsyth Institute (AFI) announced they had identified a critical factor that may contribute to the spread of hospital-acquired infections (HAIs), shedding light on why these infections are so difficult to combat. Their study… TOONS & TEASERS Enjoy our original cartoons from today and historical cartoons from yesterday illustrating COVID-19, scientific advancements, health crisis, pioneering scientists, the FDA, regulations and other topics. See More Toons COVID-19 VACATIONS REDUX COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer… IT IS A SMALL WORLD View More Small World Explore science at the microscale and nanoscale, one-billionth of a meter or about one ten-thousandth the diameter of a human hair. Current branches of microscopy range from electron, transmission and scanning to ultrafast, low-energy, photoemission and more. If you have a microscopy image that you want us to include, please e-mail: info@LifeScienceHistory.com. * * * * * * SUBSCRIBE TO OUR WEEKLY NEWS & ORIGINAL LIFE SCIENCE CARTOONS BECOME A SUBSCRIBER TODAY AND KEEP UP-TO-DATE WITH BREAKING LIFE SCIENCE NEWS & HISTORY SUBSCRIBE * indicates required Email Address * "A THING IS NOT NECESSARILY TRUE BECAUSE A MAN DIES FOR IT." ~ Oscar Wilde, Irish writer (1854-1900) LIFESCIENCEHISTORY.COM LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data. MORE * About * Life Science Heroes ADVERTISING * Banner Advertising * Advertise Your Job LEGAL * Privacy Policy * Terms of Use © 2024 LifeScienceHistory.com by James Web Design Facebook Instagram Linkedin * Home * Company Directory * CareersToggle child menuExpand * Find Your Job * Advertise Your Job * News and History * Toons & Teasers * Small World Toggle Menu Close Search for: Search